Resten-NG: Phase I data; Phase II

AVII said that in a dose-escalation Phase I trial of oral Resten-NG, no

Read the full 130 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE